Sickle cell disease: monitoring, current treatment, and therapeutics under development
C Hoppe, L Neumayr - Hematology/Oncology Clinics, 2019 - hemonc.theclinics.com
Sickle cell disease (SCD) is a complex, clinically heterogeneous disorder affecting
approximately 100,000 individuals in the United States and millions worldwide. The disease …
approximately 100,000 individuals in the United States and millions worldwide. The disease …
[HTML][HTML] Model‐based dosing with concentration feedback as an integral part of personalized hydroxycarbamide management
We read with great interest the manuscript by Estepp and colleagues where the authors
evaluated model-based strategies for predicting hydroxycarbamide (hydroxyurea) exposure …
evaluated model-based strategies for predicting hydroxycarbamide (hydroxyurea) exposure …